文献速递传染病防控与疫情报告免疫规划

重组紧密黏附素、EspB和志贺毒素2B疫苗对实验性攻击大肠杆菌O157:H7犊牛的效力

Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
PubMed 文献 · Vaccine · 2018-05-26

本研究将犊牛分为三组,分别接种EspB+IntC280、EspB+IntC280+BLS-Stx2B或不接种作为对照,接种后24天用大肠杆菌O157:H7攻击。两种疫苗均诱导血清和肠道黏膜特异性抗体并降低排菌,但添加Stx2B未比单独EspB+IntC280提供更强保护。

要点

  • 两种疫苗均显著增加血清和肠道黏膜中IntC280和EspB特异性抗体。
  • 三抗原组血清和肠道匀浆可中和Stx2细胞毒性,两抗原组与对照组则未显示。
  • 与对照组相比两种疫苗均降低大肠杆菌O157:H7排菌,但含Stx2B组未优于两抗原组。

核心结论

  • 两种疫苗均降低实验攻击后犊牛大肠杆菌O157:H7排菌,但添加Stx2B未带来优于EspB+IntC280单独接种的保护水平。

研究设计与样本

  • 犊牛分组接种EspB+IntC280、EspB+IntC280+BLS-Stx2B或不接种作为对照,接种后24天用大肠杆菌O157:H7攻击,攻击后15天处死。

主要发现

  • 两种疫苗组血清和肠道黏膜中IntC280与EspB特异性抗体均显著增加。
  • 三抗原组血清和肠道黏膜中检测到抗Stx2B抗体。
  • 三抗原组血清和肠道匀浆可中和Stx2细胞毒性,对照组和两抗原组则未显示。
  • 与对照组相比两种疫苗均降低大肠杆菌O157:H7排菌,但三抗原组未显示优于两抗原组的保护。

局限性

  • 尚需确定在长期及牛群中反复低剂量暴露后,疫苗中添加Stx2B是否改变大肠杆菌O157:H7排菌模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Escherichia coli O157:H7 is a zoonotic pathogen of global importance and the serotype of Shiga toxin-producing E.coli (STEC) most frequently associated with Hemolytic Uremic Syndrome (HUS) in humans. The main STEC reservoir is cattle. Vaccination of calves with the carboxy-terminal fraction of Intimin γ (IntC280) and EspB can reduce E.coli O157:H7 fecal shedding after experimental challenge. Shiga toxin (Stx) exerts local immunosuppressive effects in the bovine intestine and Stx2B fused to Brucella lumazine synthase (BLS-Stx2B) induces Stx2-neutralizing antibodies. To determine if an immune response against Stx could improve a vaccine's effect on fecal shedding, groups of calves were immunized with EspB + IntC280, with EspB + IntC280 + BLS-Stx2B, or kept as controls. At 24 days post vaccination calves were challenged with E.coli O157:H7. Shedding of E.coli O157:H7 was assessed in recto-anal mucosal swabs by direct plating and enrichment followed by immunomagnetic separation and multiplex PCR. Calves were euthanized 15 days after the challenge and intestinal segments were obtained to assess mucosal antibodies. Vaccination induced a significant increase of IntC280 and EspB specific antibodies in serum and intestinal mucosa in both vaccinated groups. Antibodies against Stx2B were detected in serum and intestinal mucosa of animals vaccinated with 3 antigens. Sera and intestinal homogenates were able to neutralize Stx2 verocytotoxicity compared to the control and the 2-antigens vaccinated group. Both vaccines reduced E.coli O157:H7 shedding compared to the control group. The addition of Stx2B to the vaccine formulation did not result in a superior level of protection compared to the one conferred by IntC280 and EspB alone. It remains to be determined if the inclusion of Stx2B in the vaccine alters E.coli O157:H7 shedding patterns in the long term and after recurrent low dose exposure as occurring in cattle herds.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Martorelli L, Garimano N, Fiorentino GA, et al. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7. Vaccine. 2018. PMID: 29807709. doi:10.1016/j.vaccine.2018.05.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。